Atossa Therapeutics And Quantum Leap Healthcare Collaborative Dose First Patient In Clinical Trial Evaluating (Z)-Endoxifen With Abemaciclib As Neoadjuvant Treatment For High-Risk ER+/HER2- Breast Cancer
Author: Benzinga Newsdesk | August 21, 2024 08:30am